Cardiac tissue engineering: an emerging approach to the treatment of heart failure
Frontiers in Bioengineering and Biotechnology · 15.08.2024 · 12
DOI: 10.3389/fbioe.2024.1441933 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 15.08.2024. Verfasst von Hossein Rayat Pisheh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Scienc…. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 219 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure is a major health problem in which the heart is unable to pump enough blood to meet the body’s needs. It is a progressive disease that becomes more severe over time and can be caused by a variety of factors, including heart attack, cardiomyopathy and heart valve disease. There are various methods to cure this disease, which has many complications and risks. The advancement of knowledge and technology has proposed new methods for many diseases. One of the promising new treatments for heart failure is tissue engineering. Tissue engineering is a field of research that aims to create living tissues and organs to replace damaged or diseased tissue. The goal of tissue engineering in heart failure is to improve cardiac function and reduce the need for heart transplantation. This can be done using the three important principles of cells, biomaterials and signals to improve function or replace heart tissue. The techniques for using cells and biomaterials such as electrospinning, hydrogel synthesis, decellularization, etc. are diverse. Treating heart failure through tissue engineering is still under development and research, but it is hoped that there will be no transplants or invasive surgeries in the near future. In this study, based on the most important research in recent years, we will examine the power of tissue engineering in the treatment of heart failure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Medical Biotechnology, Faculty of Allied Medicine, Iran University of Medical Science, Tehran, Iran.
- School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Biology, Payam Noor University (PUN), Shiraz, Iran.
- Shiraz Institute for Stem Cell & Regenerative Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Zitieren
APA
Rayat Pisheh, H., Nojabaei, F. S., Darvishi, A., Rayat Pisheh, A., & Sani, M. (2024). Cardiac tissue engineering: an emerging approach to the treatment of heart failure. Frontiers in Bioengineering and Biotechnology, 12. https://doi.org/10.3389/fbioe.2024.1441933
Vancouver
Rayat Pisheh H, Nojabaei FS, Darvishi A, Rayat Pisheh A, Sani M. Cardiac tissue engineering: an emerging approach to the treatment of heart failure. Frontiers in Bioengineering and Biotechnology. 2024;12. doi:10.3389/fbioe.2024.1441933
BibTeX
@article{RayatPisheh2024,
author = {Rayat Pisheh, Hossein and Nojabaei, Fatemeh Sadat and Darvishi, Ahmad and Rayat Pisheh, Ali and Sani, Mahsa},
title = {Cardiac tissue engineering: an emerging approach to the treatment of heart failure},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2024},
volume = {12},
doi = {10.3389/fbioe.2024.1441933}
}
EUVIMED